Top Markets
Coin of the day
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc.

HEPA
Peringkat dalam Saham #38984
Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is... Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is dedicated to developing therapeutic interventions for chronic hepatic ailments. Central to their efforts is Rencofilstat, a cyclophilin inhibitor that has successfully concluded Phase 2a clinical trials. This compound operates by disrupting multiple pathological pathways implicated in the worsening of liver disease. It is currently progressing through clinical development for non-alcoholic steatohepatitis (NASH) and is additionally being explored in nonclinical research for its potential to reduce liver fibrosis and lessen hepatocellular carcinoma tumor loads in experimental models of NASH. Moreover, Rencofilstat has exhibited antiviral properties against hepatitis B, C, and D viruses through diverse mechanisms. The company, established in 2013 and situated in Edison, New Jersey, rebranded as Hepion Pharmaceuticals, Inc. in July 2019, having previously operated as ContraVir Pharmaceuticals, Inc.
Harga Saham
$0.0601
Kapitalisasi Pasar
$699.79K
Perubahan (1 hari)
-14.14%
Perubahan (1 tahun)
0.17%
Negara
US
Perdagangan Hepion Pharmaceuticals, Inc. (HEPA)

Kategori

Riwayat pemecahan saham untuk Hepion Pharmaceuticals, Inc. (HEPA)
Saham Hepion Pharmaceuticals, Inc. (simbol: HEPA) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Aug 14, 2026.
Satu lembar saham HEPA yang dibeli sebelum Aug 14, 2026 sekarang setara dengan 0 lembar saham HEPA.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
Tidak cukup data untuk tanggal yang disediakan.
Pemecahan saham untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pemecahan saham Kelipatan Kumulatif Negara
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE